The Entourage Effect is not without its critics as this recent piece by Angus Chen appearing in Scientific American depicts. In fact, there is no absolute scientific evidence to either prove or disprove the Entourage Effect. The subheading of this piece is all that is needed to understand its content - Industry players swear pot’s many chemicals work in concert, but most scientists hear a THC solo. Friends you know well enough by now that when an author cannot resist using the terms of a bygone era rooted in ignorance and propaganda that I tend to become suspicious as to whether or not that that bias crept into, and therefore influenced, the work. Terms such as “pot” have no place in such published material – at least in my humble opinion. However, we must always keep it simple and the simple truth is that the Entourage Effect has not be proven … at least not yet. As an investor, imagine if it does prove to be true. Terpenes could also be used to change the profile of an array of existing traditional pharmaceuticals as well as natural remedies. When the market is as hot as it has been recently or as cold as it was previously, I see little value in joining the choirs of self-identifying Oracles who cannot wait to share with you their latest hot tip. That is why the last few months have focused on what just may lay ahead.
As with my article last month, the benefit to the Retail Investor is collateral or ancillary to the improvements in health, wellness, and treatment options. We must never lose sight of that. Even those who perhaps are not ethical investors as evidenced by using platforms (social media, bulletin boards, newsletters, email blasts, subreddit, etc) to manipulate others for their own benefit (short selling or because they are paid promoters/influencers etc) also understand full well this truth and realize that the sun is setting on their wild west. However, let’s focus now on that benefit to the Retail Investor.
In an environment of plain packing and all but non-existent marketing, the profile and composition of the cannabis itself may be a key to success. Various websites allow for strain reviews and ratings and there are plenty of competitions that recognize top
strains. Imagine if a leading cannabis data company such as Knalysis Technologies Inc
(part of the Canada House Wellness Group)
178